Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Abbott clears antitrust hurdle in AMO deal

This article was originally published in The Tan Sheet

Executive Summary

With the Jan. 5 expiration of the waiting period under the Hart-Scott-Rodino pre-merger notification program, Abbott's acquisition of Advanced Medical Optics can move forward, the pharmaceuticals and nutritionals firm says Feb. 6. Abbott has until Feb. 24 to consummate the tender offer for the eye care products company, but must also satisfy the European Commission's regulatory review. The Abbott Park, Ill.-based firm said Jan. 12 it would pay $1.36 billion for AMO's 62 million outstanding shares (1"The Tan Sheet" Jan. 19, 2009, p. 17)
Advertisement

Related Content

AMO’s last independent quarter
Abbott Targets Diversity, Reels In Advanced Medical Optics For $2.8 Billion
Abbott Targets Diversity, Reels In Advanced Medical Optics For $2.8 Billion

Topics

Advertisement
UsernamePublicRestriction

Register

PS102572

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel